Posttransplantation B lymphoblastic leukemia with Burkitt-like features

Transplantation

Volumn 67, Issue 10, 1999, Pages 1379-1380

  Tweddle, Deborah A ^a   Gennery, Andrew R ^b   Reid, Michael M ^a   Thomas, J Alero ^c   Burke, Margaret ^d   Hamilton, J R Leslie ^b   Windebank, Kevin P ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; THYMOCYTE ANTIBODY; VINCRISTINE;

ARTICLE; B CELL LEUKEMIA; CASE REPORT; CHILD; CONGENITAL HEART DISEASE; EPSTEIN BARR VIRUS; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRATHECAL DRUG ADMINISTRATION; LYMPHOPROLIFERATIVE DISEASE; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; BIOPSY; BONE MARROW; CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; EPSTEIN-BARR VIRUS INFECTIONS; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; LEUKEMIA, B-CELL, ACUTE; MALE; PREDNISOLONE;

EID: 0033609338     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199905270-00017     Document Type: Article

References (7)

1. Hunt BJ, Thomas JA, Burke M, Walker H, Yacoub M, Crawford D. Epstein-Barr virus associated Burkitt lymphoma in a heart transplant recipient. Transplantation 1996; 62(6): 869.
2. Hanto D. Classification of Epstein-Barr virus-associated posttransplant lymphoproliferative diseases: implications for understanding their pathogenesis and developing rational treatment strategies. Annu Rev Med 1995; 46: 381.
3. Tweddle DA, Windebank KP, Campbell Hewson Q, Yule SM. Cyclosporin neurotoxicity after chemotherapy. BMJ 1999; 318: 1113.
4. Knowles DM, Cesarman E, Chadburn A, et al. Correlative, morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 1995; 85(2): 552.
5. Harris NL, Ferry JA, Swerdlow SH. Posttransplant lymphoproliferative disorders: summary of Society for Haematopathology workshop. Semin Diagn Pathol 1997; 14: 8.
6. Swinnen LJ, Mullen GM, Carr TJ, Costanzo MR, Fisher RI. Aggressive treatment for postcardiac transplant lymphoproliferation. Blood 1995; 86(9): 3333.
7. Sigfússon G, Fricker J, Bernstein D, et al. Long term survivors of pediatric heart transplantation: a multicenter report of sixty-eight children who have survived longer than five years. J Pediatr 1997; 130: 862.